Mumbai: Piramal Healthcare on Friday said it has reported a 13.49% decline in consolidated net profit at Rs114.90 crore for the fourth quarter ended 31 March.
The pharma firm had a net profit of Rs132.82 crore in the March quarter of FY08, Piramal Healthcare said in a filing to the Bombay Stock Exchange (BSE).
The firm’s net sales rose 9.34% at Rs850.91 crore in the March quarter, from Rs778.20 crore in the same period last fiscal.
During the March quarter, the firm incurred a foreign exchange loss of Rs16.90 crore, against a forex gain of Rs10.33 crore in the year-ago period.
The board has declared a dividend of 210% for FY09, at the rate of Rs4.20 a piece, on shares of face value of Rs2.
For FY09, Piramal Healthcare posted a net profit of Rs316.25 crore, down 5.25% from Rs333.78 crore in FY08.
The net sales for FY09 rose to Rs3,281.10 crore, from Rs2,867.48 crore in FY08.
Shares of Piramal Healthcare were trading at Rs214, up 3.13% in the late afternoon trade on the BSE.